Development of a population pharmacokinetic model for parecoxib and its active metabolite valdecoxib after parenteral parecoxib administration in children.
about
Inhibition of cyclooxygenase-2 prevents intra-abdominal adhesions by decreasing activity of peritoneal fibroblastsPain in children--are we accomplishing the optimal pain treatment?Efficacy and safety of perioperative parecoxib for acute postoperative pain treatment in children: a meta-analysis.Pharmacokinetics and analgesic effectiveness of intravenous parecoxib for tonsillectomy ± adenoidectomy.Parecoxib sodium reduces the need for opioids after tonsillectomy in children: a double-blind placebo-controlled randomized clinical trial.
P2860
Development of a population pharmacokinetic model for parecoxib and its active metabolite valdecoxib after parenteral parecoxib administration in children.
description
2012 nî lūn-bûn
@nan
2012 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Development of a population ph ...... ib administration in children.
@ast
Development of a population ph ...... ib administration in children.
@en
Development of a population ph ...... ib administration in children.
@nl
type
label
Development of a population ph ...... ib administration in children.
@ast
Development of a population ph ...... ib administration in children.
@en
Development of a population ph ...... ib administration in children.
@nl
prefLabel
Development of a population ph ...... ib administration in children.
@ast
Development of a population ph ...... ib administration in children.
@en
Development of a population ph ...... ib administration in children.
@nl
P2093
P1433
P1476
Development of a population ph ...... xib administration in children
@en
P2093
Bruce Hullett
Deborah Peirce
Kenneth F Ilett
Kylie Davies
Sean J O'Halloran
P304
P356
10.1097/ALN.0B013E31825154EF
P407
P50
P577
2012-05-01T00:00:00Z